NEW YORK, Oct 31 –Pharmacogenomics technology company Variagenics of Cambridge, Mass., said Tuesday strong revenue growth helped to the company to narrow its third quarter net losses to $6.4 million, or 35 cents a share, compared with losses of $6.6 million, or $10.75 a share a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.